Brent Kendall wrote an article in the Wall Street Journal about Allergan's product Lap-Band being avaiable to more people. The Food and Drug Administration has agreed to lower the minimal age and weight index in order to qualify for this product. Lap-Band is used in eligible diabetic patients to lose weight. Although this is only a minor product of Allergan, this massive corporation expects a gain of $220 million this year because of the new regulation.
The Lap-Band is an inflatable silicone ring that is placed around the upper part of the stomach. It restricts how much a person can eat and makes one feel full more quickly.
Although this product will undoubtedly help thousands of Americans to counter and control their diabetic problem early in their life, one can not ignore the fact that the government has given another leeway to a company, that is already making millions, to make more money. In this case, diabetes is a haunting problem especially all over America and this product has been proven to be used widely due to its success. A problem that might occur in the near future is that other health and beauty product related companies may use this as an example in order to gain favor for their demands as well.
No comments:
Post a Comment